Cortisol Testing in Septic Shock: An Evaluation of Diagnostic Performance and Predictors of Corticosteroid Use in a

Fayez Alshamsi1, Saeed Alkaabi1, Maryam Nasser Mohamedali Alfadli1

  • 1Department of Internal Medicine, College of Medicine and Health Sciences, United Arab Emirates University, Al Ain P.O. Box 15551, United Arab Emirates.

PubMed

Insights

Baseline total cortisol levels showed poor accuracy in diagnosing critical illness-related corticosteroid insufficiency (CIRCI) in septic shock patients. Clinical judgment, not cortisol testing, is crucial for guiding corticosteroid therapy in this population.

Area of Science:

  • Critical care medicine
  • Endocrinology
  • Sepsis research

Background:

  • Diagnosis of critical illness-related corticosteroid insufficiency (CIRCI) is challenging due to sepsis pathophysiology.
  • International guidelines now favor clinical evaluation over strict cortisol thresholds for adrenal insufficiency.
  • Applicability of revised diagnostic approaches in non-Western populations is unknown.

Purpose of the Study:

  • To assess the diagnostic accuracy and clinical utility of baseline total cortisol levels.
  • To guide corticosteroid therapy in intensive care unit (ICU) patients with septic shock in the UAE.
  • To evaluate cortisol's role in a non-Western cohort.

Main Methods:

  • Retrospective observational study of ICU patients with septic shock (2012-2022).
  • CIRCI defined by clinical decision to administer hydrocortisone >24 hours.
  • Receiver Operating Characteristic (ROC) and Decision Curve Analysis (DCA) used.

Main Results:

  • 13 of 43 patients (30.2%) received hydrocortisone; mean cortisol was higher in this group (p=0.24).
  • ROC analysis showed poor diagnostic performance (AUC 0.61); guideline cutoff had 0% sensitivity.
  • Clinical factors (vasopressor use, shock duration) predicted therapy; cortisol levels did not.

Conclusions:

  • Baseline total cortisol has poor diagnostic accuracy and lacks clinical utility in guiding corticosteroid therapy for septic shock.
  • Clinical judgment is paramount for identifying patients requiring corticosteroid therapy, aligning with international guidelines.
  • Findings emphasize reliance on clinical assessment over biochemical markers in this cohort.

Related Concept Videos

COPD: Management Using Bronchodilators and Corticosteroids01:26

COPD: Management Using Bronchodilators and Corticosteroids

Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
1.2K
Pericarditis II: Clinical Features and Diagnostic Tests01:19

Pericarditis II: Clinical Features and Diagnostic Tests

Pericarditis is distinguished by inflammation of the pericardium, the fibrous sac that encases the heart. It can be acute, lasting less than six weeks, or chronic, persisting for over three months. Understanding its clinical manifestations and diagnostic findings is crucial for timely and effective management.Clinical ManifestationsWhile pericarditis can be asymptomatic, it usually presents with characteristic symptoms such as:Chest Pain: The most characteristic symptom of pericarditis is chest...
633
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
495
Acute Kidney Injury IV: Diagnostic Studies and Prevention01:30

Acute Kidney Injury IV: Diagnostic Studies and Prevention

Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...
559
Cushing Syndrome I: Introduction01:26

Cushing Syndrome I: Introduction

Cushing syndrome refers to the collection of clinical manifestations that arise when tissues are exposed to excessive amounts of cortisol or cortisol-like medications over an extended period. Cortisol, a glucocorticoid produced by the adrenal cortex, regulates metabolism, immune responses, and the body’s adaptation to stress. When its concentration remains chronically elevated, these physiological pathways become dysregulated, resulting in the characteristic features of the...
36
Cushing Syndrome II: Pathophysiology01:19

Cushing Syndrome II: Pathophysiology

Cortisol production is normally governed by the hypothalamic–pituitary–adrenal (HPA) axis, which maintains hormonal balance through tightly regulated feedback mechanisms. Disruption of this regulatory system is central to the development of Cushing syndrome, whether the excess cortisol originates from external medications or internal pathology. Persistent cortisol elevation alters metabolism, immune function, and endocrine signaling, producing the characteristic clinical features...
24